Risk factors for severe respiratory syncytial virus infection among Alaska Native children

Pediatrics

Volumn 109, Issue 2 I, 2002, Pages 210-216

  Bulkow, Lisa R ^a   Singleton, Rosalyn J ^a   Karron, Ruth A ^b   Harrison, Lee H ^c,d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alaska Natives; Breastfeeding; Respiratory syncytial virus

Indexed keywords

MATERNAL ANTIBODY; VIRUS ANTIBODY;

ARTICLE; BREAST FEEDING; CONTROLLED STUDY; CROWDING; ENVIRONMENTAL FACTOR; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; UMBILICAL CORD BLOOD; UNITED STATES; VIRUS INFECTION;

ALASKA; BREAST FEEDING; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INUITS; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 18244362359     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.2.210     Document Type: Article

References (32)

1. Bronchiolitis-associated hospitalizations among US children, 1980-1996
2. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997
3. Hospitalizations for respiratory syncytial virus infection in Alaska Native children
4. Severe respiratory syncytial virus disease in Alaska Native children
5. Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in northeast England
6. Diseases of importance in the United States
7. Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus
8. Provision of health care in a frontier setting: An Alaskan perspective
9. Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia-RSV recombinants or RSV
10. Variation in severity of respiratory syncytial virus infections with subtype
11. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level
12. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation
13. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia
14. Respiratory syncytial viral infection in infants with congenital heart disease
15. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus
16. Maternal antibody and respiratory syncytial virus infection in infancy
17. Respiratory syncytial virus in early infancy: Circulating antibody and the severity of infection
18. Breastfeeding and respiratory virus infection
19. Breast-feeding protects against respiratory syncytial virus infection
20. Breast-feeding and respiratory syncytial virus infection
21. Day care center attendance and hospitalization for lower respiratory tract illness
22. Advances in prevention of respiratory syncytial virus infections
23. Infant health and breast-feeding during the first 16 weeks of life
24. Relationship of infant feeding to recurrent wheezing at age 6 years
25. Relation between infant feeding and infections during the first six months of life
26. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life
27. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis
28. The effect of maternal smoking during pregnancy on early infant lung function
29. Relationship of parental smoking to wheezing and non-wheezing lower respiratory tract illnesses in infancy
30. Risk factors for acute wheezing in infants and children: Viruses, passive smoke, and IgE antibodies to inhalant allergens
31. Wood burning stoves and lower respiratory illnesses in Navajo children
32. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion